LY3200882 – 25 mg

Brand:
Cayman
CAS:
1898283-02-7
Storage:
-20
UN-No:
Non-Hazardous - /

LY3200882 is an ATP-competitive inhibitor of TGF-β receptor type 1 (TGF-βRI).{43234} It inhibits TGF-β-induced SMAD phosphorylation in vitro and in vivo and exhibits antitumor activity in the 4T1-LP triple negative breast cancer orthotopic tumor model.  

 

Available on backorder

SKU: 25276 - 25 mg Category:

Description

An inhibitor of TGF-βRI; inhibits TGF-β-induced SMAD phosphorylation in vitro and in vivo; exhibits antitumor activity in the 4T1-LP triple negative breast cancer orthotopic tumor model


Formal name: 4-[[4-[[1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]oxy]-2-pyridinyl]amino]-α,α-dimethyl-2-pyridinemethanol

Synonyms: 

Molecular weight: 435.5

CAS: 1898283-02-7

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|Activin-like Kinases (ALKs)||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|ALK (Activin-like Kinase) Signaling